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Abstract 
Background: Obesity-induced hyperglycemia as seen in type 2 diabetes, may predispose 
people to impaired immune function dysregulated neutrophils, which will then increase 
their susceptibility to influenza virus infection. 
Objective: My goal was to study the effect of obesity-induced abnormal glucose 
metabolism on neutrophil function and to determine whether neutrophil function and 
activation is affected by exposure to glucose at hyperglycemic levels. I hypothesized that 
hyperglycemia will have a strong effect on the ability of neutrophils to function and will 
cause their dysregulation, displayed by a lower generation of influenza virus titers and 
higher cell counts in hyperglycemic conditions.  
Design: HL-60 cells were grown, differentiated into neutrophils, and infected with 1, 10, 
and 100 HAU of PR8/H1N1 influenza virus  in different glucose concentrations for 24 
hours. Post-infection, morphological changes were observed, cell viability was assessed, 
and a TCID50 assay was conducted to determine infectious virus titers.  
Results: No significant link was found between hyperglycemia and dysregulated 
neutrophils (HL-60 cells). Glucose, therefore, had no effect on the ability of HL-60 cells to 
grow or the TCID50 titers.  There was a significant link in the amount of virus used. 100 HAU 
killed more cells than 10 HAU and 1 HAU and there was a significant difference in the 
amount of growth with and without virus exposure.  Additionally, there was a significant 
difference in the TCID50’s depending on if the virus concentration was 1 HAU, 10 HAU or 
100 HAU, except for between 1 HAU and 10 HAU.  
Conclusion: Future research regarding a link between hyperglycemia and neutrophil 
dysregulation should be conducted.  
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I. Obesity & Type 2 Diabetes  
The prevalence of childhood and adult obesity has increased in the past thirty years 
dramatically1. Obesity, defined as a body mass index greater than 30 kg/m2, is associated 
with countless problems related to impaired immune function. Type II Diabetes is a 
polygenic disease, meaning that a number of factors can contribute to one’s susceptibility 
for the disease. However, the recent increase in obesity has been thought to be due to the 
inability of the body to cope with high-energy food intake, a sedentary lifestyle, and 
perhaps a lack of exercise2.  
Obesity is a major cause of type II diabetes (T2D), clinically evidenced by 
hyperglycemia (high blood glucose)2. Obesity-induced diabetes is developing as a global 
health care problem with projections that it will reach pandemic levels by 20302. Obesity-
induced diabetes has historically been known to affect adults, however in recent years 
there has been an increase amongst children. The disorder is characterized by a decrease in 
insulin signaling via insulin resistance and downstream proteins, resulting in an 
impairment in the proper use of insulin. Insulin is vital hormone that allows glucose to be 
released and used by the body. However, the exact impairments contributing to the 
development of insulin resistance still remain unknown2.  
Hyperglycemia, a condition of too much glucose in the body, develops in later stages 
of diabetes. This occurs when pancreatic beta cells can no longer compensate for the high 
levels of insulin resistance in the peripheral tissues2. 
In clinical settings, assessment of plasma glucose control is done by monitoring 
hemoglobin A1C (HbA1c) and fasting blood glucose levels. HbA1c provides an average 
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indication of glucose controls during 6-8 weeks prior to sampling3. Hyperglycemia, 
clinically evidenced by an HbA1c level of >48 mmol/mol or >6.5% corresponds to a plasma 
glucose level of anywhere from 7.8 mM to 18 mM4.  
The current criteria recommended by WHO in diagnosing diabetes is a fasting 
glucose cut-off of  ≥7.0 mM for diagnosis of diabetes. The pre-diabetes category known as 
“impaired fasting glycemia” is  defined as a fasting glucose between 6.1 mM and 6.9 mM. 
Additionally, diabetes can also be diagnosed following a 75 g glucose load, in which case 
≥11.1 mM would be considered diabetic5.  
Although rare, individuals with T2D may also experience euglycemia (normal 
glucose levels 5.5 mM) or hypoglycemia (low glucose levels, <60 mg/dL or 3.3 mM) despite 
serious insulin resistance2. Hypoglycemia is typically a side effect of treatment with blood-
sugar lowering medication.  
In this experiment, a range of blood glucose levels corresponding to diagnosis after 
receiving a “load” of glucose were chosen to be tested to see if there were differences in 
their metabolic implications (16.5 mM, 12 mM, 7 mM, 5.5 mM, 3.3 mM).  
II. Obesity and Influenza Virus  
Nutritional biochemistry studies have identified a link between obesity, impaired 
immune function, and infectious diseases. Obesity has been recognized as an important risk 
factor for infection with the influenza virus, as shown in a 2009 study where obese 
individuals experienced a greater severity of illness from influenza pandemic from the 
H1N1 virus6. Although influenza epidemics have the potential to affect all populations, the 
greatest risk of complications occur amongst children, or individual with certain medical 
conditions that weaken the immune system, such as type 2 diabetes7.   
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The influenza virus is a serious public health problem, causing severe illness and 
death in high-risk populations7. It is one of the most common and widely spread infectious 
diseases. Since it is a contagious respiratory disease, the disease can have serious outcomes 
if infected resulting in hospitalization or death. The severity or burden of the disease in the 
United States depends on a number of factors including the timing of the season, 
characteristics of certain viruses, and how well the vaccine works7 . 
The influenza virus belongs to the family of Orthomyoxviridea. The viruses are 
enveloped and contain a segmented single-stranded RNA genome of negative polarity8. 
There are four types of influenza virus: A, B, C and D. The two main viruses are A 
and B, who, and their subtypes, routinely spread in people and are responsible for seasonal 
flu epidemics. Influenza A viruses are divided into subtypes based on the proteins on the 
surface of the virus: hemagglutinin (H) and neuraminidase (N). The influenza A virus is 
further broken down in terms of strain: influenza A H1N1 and influenza A (H3N2). 
Influenza B viruses are not divided into subtypes, but do differ in strains and lineages: 
B/Yamagata and B/Victoria Influenza type C infections typically only cause a mild 
respiratory illness and are not thought to cause epidemics. Influenza D viruses primarily 
affect cattle, with very little information known to cause illness7. For this study, the 
Influenza A/Puerto Rico/8/1934(H1N1) strain was used. This strain of virus is mouse-
adapted, and is highly pathogenic to mice, causing death in less than a week at 600 
infectious particles9. Humans do not become infected with this strain. 
Animals and tissue culture models of influenza virus are useful in researching and 
understanding the nature behind the virus and transmission in humans. PR8 infection in 
mice is used as a model system that mimics pathological features seen with the 1918 virus, 
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including efficient alveolar spread, fatal viral pneumonia, acute pulmonary hemorrhage, 
and extraordinarily strong host responses10.   
Mice infected with PR8/H1N1 virus lost weight rapidly and displayed evidence of 
severe clinical disease (huddling, labored breathing). Additionally, their neutrophil 
numbers increased over time following infection9.   
III. Neutrophils. 
 Neutrophils are infection-fighting immune cells that have been proposed to 
participate in protection against intracellular pathogens (viruses and mycobacteria) and 
play a role in physiological and pathological processes beyond the immune system, such as 
diabetes11. Studies have shown neutrophil accumulation in the lungs of mice infected with 
the lethal influenza strain within two days of infection and several days before the mice 
grew severely ill, suggesting that neutrophils play a key role in immune function10.  
Following infection with the influenza virus, neutrophils are rapidly recruited to the 
respiratory tract in humans and mice. The current evidence suggests a “protective” role 
that neutrophils play following infection of mice with the mouse-adapted A/PR/8/34 strain 
(PR8, H1N1)10. It has also been found that depletion of neutrophil attracting chemokines 
were associated with reduced neutrophil recruitment which may suggest that a 
dysregulated response in airways may contribute to disease during severe influenza 
infections9. 
Neutrophil infiltration is correlated with the level of inflammation, tissue damage 
and feed-back of an affected tissue. One study found that neutrophils potentially amplify 
their own recruitment to infected areas in a feedforward manner, releasing more 
attractants (chemokines) for other neutrophils to follow10.   
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The specific role of neutrophils during mild and severe influenza virus infections 
remains unclear, however neutropenic mice lose weight and succumb to PR8 infection 
more rapidly than control animals10.  
T2D, a common complication of obesity, can result in immune dysfunction, including 
increased blood neutrophil counts2. In the case of T2D, elevated glucose levels may impair 
the function of neutrophils, which can result in secondary infections if neutrophils are not 
efficiently recruited13.  
IV. HL-60 cells  
 HL-60 cells are a peripheral blood mononuclear cell line derived by S.J. Collins, et al., 
14. The peripheral blood leukocytes were obtained by leukophresis from a 36-yr-old 
Caucasian female with acute promyleocytic leukemia. Less than 10% of the cultured cells 
spontaneously differentiate beyond the promyelocytic stages and the proportion is 
enhanced by compounds such as DMSO, retinoic acid, butyrate, hypoxanthine, TPA, and 
actinomycin D. HL-60 cells lack specific markers for lymphoid cells but express surface 
receptors for Fc fragment and complement. They exhibit phagocytic activity and 
responsiveness to chemotaxis stimuli14. 
 Upon differentiation into neutrophils, HL-60 cells display several different 
morphologies: a) ovioid, b) indented, c) lobulated, d) lobulated (left), and e) multilobed 
(right), and f) multi-lobed15 (Figure 1). In this experiment, HL-60 cells are used as a 
neutrophil cell line in vitro.  
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Figure 1: HL-60 Cells Terminally Differentiated into Neutrophils15  
V. Theoretical Framework:  
Previous biochemistry studies have illustrated a relationship between obesity, 
impaired immune function, and susceptibility to influenza virus. T2D, a common 
complication of obesity, can result in immune dysfunction, including increased blood 
neutrophil counts12. Human promeolytic leukemia cells, (HL-60 cells) a neutrophil cell line, 
will be used to determine if altering glucose levels affects the function of neutrophils (HL-
60 cells) to respond to influenza infection. This research proposes that hyperglycemia as 
seen in T2D, caused by obesity, predisposes people to impaired immune function 




Specific Aims and Hypothesis 
Aim 1: Study the effect of obesity-induced abnormal glucose metabolism on 
neutrophil function. 
My first aim is to determine whether neutrophil function and activation is affected 
by exposure to glucose at hypoglycemic, normal, and hyperglycemic levels, using HL-60 
cells, a neutrophil cell line.  I hypothesize that hyperglycemia will have a strong effect on 
the ability of neutrophils to function and will cause their dysregulation demonstrated by a 
lower generation of influenza virus titers than normal and hypoglycemic conditions.  
Aim 2: Study the effect of obesity-induced abnormal glucose metabolism on 
neutrophil viability. 
 I hypothesize that hyperglycemia will have a strong effect on neutrophil viability 
and will cause their dysregulation demonstrated by a higher cell counts in areas exposed to 
hyperglycemia and higher virus concentrations and more dead cells in areas with lower 
cell counts. 
MATERIALS AND METHODS 
Cells and Viruses 
HL-60 cells (ATCC) were maintained in RPMI medium supplemented with 20% FBS 
and 1% penicillin/streptomycin. The cells were passaged when the cells reached a density 
between 1 and 2 million cells/mL in 25 cm^2 and 75cm^2 flasks. Cells were passaged 
every 3-4 days and maintained at 37 degrees Celsius and 5% CO2 in standard tissue culture 
incubator. Under differentiation, the cells were additionally supplemented with HEPES 
buffer.  
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Washed turkey red blood cells from Lampire Biological were used for all 
heamagglutination-based assays. MDCK cells were maintained in EMEM essential medium 
supplemented with 10% FBS with added glutamine and 1%penicillin/streptomycin.  
The influenza virus A/Puerto Rico/8/34 H1N1 virus grown from a stock solution 
from (2010) was used for all assays of the experiment.  
RPMI-Glucose Free Media Preparation 
The RPMI glucose-free medium was used in the experiments for all glucose 
conditions and the RPMI glucose-free medium control. 2.14 g of powdered RPMI-1640 
Deficient obtained from Sigma-Aldrich was dissolved in 225 mL of distilled water at room 
temperature. The water was not heated. 0.50 grams of sodium bicarbonate was added to 
the solution and the solution was stirred until dissolved. The pH of the solution was 
adjusted to 7.2 and filtration was used to sterilize the solution immediately. Medium was 
supplemented with 20% FBS and 1% penicillin/streptomycin stored in the refrigerator at 4 
degrees Celsius.  
Glucose Concentrations Preparation 
All glucose concentrations were prepared from a 1M stock solution of D-Glucose. 
180.1 g of D-glucose was dissolved in 1L of sterile water.  6 mL of each glucose 
concentration was prepared before each experiment. The 16.5 mM solution was prepared 
by collecting 99 microliters of 1 M glucose and diluting with 5.90 mL of water. 12 mM was 
prepared by collecting 72 microliters of 1 M glucose and diluting with 5.928 mL of water. 7 
mM was prepared by collecting 42 microliters of 1 M glucose and diluting with 5.958 mL of 
water.  5.5 mM was prepared by collecting 33 microliters of 1 M glucose and diluting with 
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5.967 mL of water. And 3.3 mM glucose was prepared by collecting 19.7 microliters of 1M 
glucose and diluting with 5.980.2 mL of water.   
Analytic Methods 
Study Design: 
1. Testing Undifferentiated HL-60 Cells in Different Glucose Concentrations 
To establish a baseline for this research and to ensure that glucose would not kill the 
HL-60 cells, undifferentiated HL-60 cells were tested in different glucose concentrations: 
500,000 cells/mL were plated in a 12-well plate and exposed to 1 mL of various glucose (& 
glucose-deficient) concentrations:  16.5 mM, 5.5 mM, RPMI glucose free, and RPMI with 
glucose and L-glutamine (11.1 mM) for 24 hours. Each condition was assessed in triplicate. 
The glucose concentration solutions and the RPMI glucose-free solution were all prepared 
using the RPMI glucose-free media, while the RPMI with glucose solution was prepared 
with the normal growth medium for the cells.  
After a 24-hour exposure to each condition, cell viability was assessed using a 
hemocytometer, the most common method of determining cell number. A haemocytometer 
is a thick glass slide with two counting chambers, each 0.1 mm deep. Each chamber is 
divided into nine large squares and the center square is divided into 25 squares which 
further subdivide into 16 squares16. 
A uniform cell suspension of 100 microliters was prepared with each condition. A 1:2 
dilution with Trypan Blue, the most common stain used to distinguish viable cells from 
non-viable cells was performed. Only non-viable cells absorb the Trypan Blue dye and 
appear blue and perhaps, asymmetrical. Live, healthy cells appear round and do not absorb 
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the dye. Additionally, because addition of the dye is time-sensitive, dilutions must be 
performed just prior to counting to avoid false data.  
The haemocytometer was placed on the stage of an inverted microscope and adjusted 
for focus (40x-100x magnification). Cells were counted in each of the 4 corner and central 
squares and an average of the cell count was taken. 





# 𝑜𝑓 𝑐𝑒𝑙𝑙𝑠 𝑐𝑜𝑢𝑛𝑡𝑒𝑑
# 𝑜𝑓 𝑠𝑞𝑢𝑎𝑟𝑒𝑠 𝑐𝑜𝑢𝑛𝑡𝑒𝑑
 𝑥 104 𝑥 𝑑𝑖𝑙𝑢𝑡𝑖𝑜𝑛 𝑓𝑎𝑐𝑡𝑜𝑟 (2) 
2. Differentiating HL-60 Cells 
Cells were differentiated in culture medium containing 2.0% DMSO. Previous studies 
have shown differentiation at 1.3-1.5% DMSO, but in this study, only 80% of cells showed 
differentiation under these conditions. Under 2.0% DMSO, approximately 85% of cells 
were differentiated. DMSO was premixed with the medium before adding cells due to its 
viscous and dense nation. Differentiation was determined by assessing morphological 




Figure 2: Neutrophil Differentiation17.  
3. Determining Infectious Titer  
An HAU assay was performed to determine the concentration of virus. 
Hemagglutination units, or HAU, are defined as the reciprocal of the highest dilution of 
virus that still allows agglutination of red blood cells.  
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Washed turkey red blood cells (TRBC’s) of 0.05% was prepared by adding 2 mL of 
RBC’s to a 15-mL conical tube. 10 mL of sterile PBS was added to the tube and the tube was 
centrifuged for 10 minutes at 4 degrees Celsius, 270g, 5 deceleration. The previous step 
was repeated twice and the size of the RBC pellet was estimated following the third 
centrifuge spin. Based on the size of the pellet, DPBS was added to yield a 0.5% packed RBC 
suspension. Two-fold virus dilutions of PR8/H1N1 were prepared to determine the 
dilution of the virus.  
The sialic acid receptors on the surface of the RBCs bind to the hemagglutinin 
glycoprotein found on the surface of influenza virus & create a network of structures of 
interconnected virus particles. 
The relative concentration or titer of the virus is based on the well with the last 
agglutinated appearance immediately before a pellet is observed. The PR8/H1N1 virus 

























Figure 3B: HAU of PR8/H1N1 (back) 
4. Testing Differentiated HL-60 cells in different glucose concentrations  and 
infecting them with influenza virus 
48,000 cells/100 microliters were plated in a 96-well plate and exposed to 
100 microliters of various glucose (& glucose-deficient) concentrations:  16.5 mM, 
12 mM, 7 mM, 5.5 mM, 3.3 mM, RPMI glucose-deficient, and RPMI with glucose and 
L-glutamine (11.1 mM) for 24 hours. Each condition was assessed in triplicate. The 
glucose concentration solutions and the RPMI glucose-free solution were all 
prepared using the RPMI glucose-free media, while the RPMI with glucose solution 
was prepared with the normal growth medium for the cells.  
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1 HAU, 10 HAU, and 100 HAU concentrations of the influenza virus A/Puerto 
Rico/8/34 H1N1 were prepared and 25 microliters of each concentration of virus 
was added to the wells containing the cells and glucose (except for the control).  
After a 24-hour exposure to each condition, cell viability was assessed using 
a hemocytometer, cell morphological changes were assessed with a microscope, and 
an infectious titer comparison was performed with a TCID50 assay. This time point 
was chosen because it corresponded to an initial peak in the airways of experiments 











Figure 4: Experimental Set Up 
5. Determining Cell Viability Post Infection with Influenza Virus  
Cell viability was determined via haemocytometry. After a 24-hour exposure to each 
condition, cell viability was assessed using a hemocytometer. A uniform cell suspension of 
130 microliters was prepared with each condition. A 1:2 dilution with Trypan Blue was 
 17 
performed and the number of cells were determined based on the same equation listed 
previously.  
6. Infectious Titer Comparison via TCID50 Assay  
The virus titers were determined by performing a tissue culture infectious dose 
(TCID50) assay. This assay quantifies the amount of virus needed to kill 50% of infected 
hosts or to produce a cytopathic effect in 50% of inoculated tissue culture cells.  
I. Seeding MDCK Cells in Round Bottom Plates 
0.8 mL of 0.25% cell culture trypsin without EDTA was added to 100-mL of serum-
free EMEM with glutamine and antibiotics just before use. A confluent 75 cm2 flask of 
MDCK cells were trypsinized and resuspended in 40 mL of growth medium. 100 uL of the 
cells were seeded in each well in a 96-well round bottom plates using a multichannel 
pipette then incubated overnight at 37 C. Seeding was considered successful the following 
day if under the microscope, there was he presence of healthy attached cells.  
II. Preparing Virus Dilutions: Same procedure for each glucose condition 
180 uL of trypsin-containing medium was dispensed into each well of a sterile, 
round-bottom 96-well plate. 20 uL of virus suspension was dispensed into the first well of 
each row. Tips were changed, the suspension was mixed and 20 uL was transferred from 
column 1 to column 2 until 10 fold dilutions were completed until 10-6. The final set up 
contained 6 replicates of each virus dilution. See set-up below 
16.5 mM Glucose 12 mM Glucose 
 1 2 3 4 5 6 1 2 3 4 5 6 
A 10-1 10-2 10-3 10-4 10-5 10-6 10-1 10-2 10-3 10-4 10-5 10-6 
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B 10-1 10-2 10-3 10-4 10-5 10-6 10-1 10-2 10-3 10-4 10-5 10-6 
C 10-1 10-2 10-3 10-4 10-5 10-6 10-1 10-2 10-3 10-4 10-5 10-6 
D 10-1 10-2 10-3 10-4 10-5 10-6 10-1 10-2 10-3 10-4 10-5 10-6 
E 10-1 10-2 10-3 10-4 10-5 10-6 10-1 10-2 10-3 10-4 10-5 10-6 
F 10-1 10-2 10-3 10-4 10-5 10-6 10-1 10-2 10-3 10-4 10-5 10-6 
G 10-1 10-2 10-3 10-4 10-5 10-6 10-1 10-2 10-3 10-4 10-5 10-6 
H 10-1 10-2 10-3 10-4 10-5 10-6 10-1 10-2 10-3 10-4 10-5 10-6 
 
III. Inoculating Cell Plates with Virus 
 The medium from the MDCK cell plates was removed by gently turning over the 
plates and giving a gentle flick to discard the medium on a diaper. 100 uL of each virus 
dilution from the predilution plate was transferred to the corresponding well containing 
MDCK cells. The plates were incubated in the CO2 incubator at 35-37 C for 5 days.  
IV. Hemagglutination Assay 
  After 5 days, a hemaglutination assay was performed with 0.75% suspension of 
freshly-washed turkey red blood cells.   
 50 uL of the 0.75% turkey rbc suspension was dispensed into each well of the plate 
containing virus dilutions, the plate was mixed by tapping the edge gently, and then 
allowed to settle for 2-2.5 hours. The last well in each virus dilution showing any degree of 
hemagglutination was recorded as positive.  The inverse of the dilution, where 50% of the 
wells showed hemagglutination was determined to be the 50% TCID50.  
7. Statistical Analysis 
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Measures of significance were analyzed via a t-test & ANOVA.  
------------------------------------------------------------------------------------------------------------ 
RESULTS: 
I. Testing Undifferentiated HL-60 Cells in Different Glucose Concentrations 
An ANOVA statistical analysis revealed that the only significance for testing 
undifferentiated HL-60 cells was between 16.5 mM glucose concentration and normal 
media and the RPMI glucose-free media and normal media. The fact that most cells grew in 
the RPMI glucose-free media indicated that glucose did not have an effect on the growth of 
HL-60 cells and they may use another nutrient (20% FBS, glutamine) preferentially as a 
fuel source.  
II. Differentiating HL-60 Cells  
Following the protocol mentioned above, HL-60 cells were differentiated. After 5 days, 
85% of the cells were determined to have the neutrophil morphological characteristics 
(Figure 1).  
III. Morphological Changes Observed Post- 24 hour Infection of HL-60 Cells 
with Influenza Virus. 
In humans, a mature differentiated neutrophil, a polymorphnuclear granulocyte, 
exhibits a lobulated or segmented nucleus with shrunken nucleoli and extensive 
peripheral heterochromatin. It is released into the bloodstream and circulates as a 
round, unpolarized cell. The neutrophil responds to chemotaxic agents produced by 
infection and tissue damage, changing shape and converting to a rapidly migrating 
shape19. 
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Figures 5-8 depict the HL-60 cells in the various experimental conditions. Upon 
infection with PR8/H1N1, the cells began to show a clumping morphology in the 1 HAU, 
10 HAU, and 100 HAU conditions. This clumping is an indication that the cells are 
infected and responding to the chemotaxic agents produced by the influenza virus. 
Additionally, the cells experienced a change in volume. Many of the cells appeared 
completely different than how they looked either prior to differentiation or upon 
differentiation before exposure to glucose or the influenza virus. There was however, 
no noticeable differences among the morphologies between different glucose 
concentrations.  
Figure 5: Morphological Changes observed in16.5 mM and 12 mM 
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Figure 6: Morphological Changes observed in 7 mM and 5.5 mM 
Figure 7: Morphological Changes observed in 3.3 mM and RPMI glucose-deficient mM  
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Figure 8: Morphological Changes observed 11.1 mM  
IV. Cell Viability Post- 24-hour Infection of HL-60 Cells with Influenza Virus   
Cell viability was determined after 24 hours of exposure to the influenza virus. A 
haemocytometer was used to count the cells. Each cell well began with 48,000 cells. The 
most cell growth occurred in the control group, exposed only to glucose. Exposure to 100 
HAU resulted in the most death of cells.  The percent change and increase in the number of 
cells were also monitored and recorded (Table 2).   
Table 1: Cell Viability 24 hours Post Infection with Influenza Virus 
Glucose 
Condition 
Glucose Only  
(Control) 
1 HAU 10 HAU 100 HAU 
16. 5 mM 215000 60000 60000 10000 
12 mM 120000 85000 90000 15000 
7 mM 320000 20000 15000 10000 
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5.5 mM 210000 95000 10000 20000 
3.3 mM 180000 60000 50000 15000 
RPMI-
glucose 
deficient 190000 110000 70000 25000 
RPMI-




Figure 9: Overall Cell Growth In Different Virus Conditions. Statistical ANOVA test revealed 
that p< 0.0001. There exists a significant difference between the number of cells in each 
virus condition except 1 HAU vs. 10 HAU. (Control vs. 1 HAU, Control vs. 10 HAU, Control 












Figure 10: Overall Cell Growth In Different Glucose Conditions. Statistical ANOVA test 
revealed that p= 0.6810. There exists no significant difference between the number of cells 
in each glucose concentration.  
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7 mM 566.67 -58.33* -68.75* -79.17* 

































































































Figure 11: Overall Percent Change In Different Virus Conditions. Statistical ANOVA test 
revealed that p<0.001 in Control vs. 1 HAU, Control vs. 10 HAU, and Control vs. 100 HAU. 
















































RPMI normal (11.1 mM)
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difference between the percent cell change in the control conditions as compared to each 












Figure 12: Overall Percent Change In Different Virus Conditions. Statistical ANOVA test 
revealed that p= 0.992. There exists no significant difference between the percent cell 
growth in each virus condition. 
V. Infectious Titer Comparison Post Infection with Influenza Virus  
The TCID50’s of the various conditions are listed below (Table 3).  The TCID50 quantifies 
the amount of virus needed to kill half of the infected cells.  For example, the 16.5 mM, 1 
HAU TCID50 would be interpreted as: “In a 1: 31622.78 dilution, 0.02 mL of virus will infect 
half of the cells”.  
 






































































16. 5 mM 31622.78 3162.28 39810.72 
12 mM 562.34 5623.42 25118.86 
7 mM 1000 5623.36 39810.74 
5.5 mM 562.34 10000 39810.74 




1000.00 3162.28 100000.00 
RPMI-
normal 





































































Figure 13: TCID50 Titers in Different Virus Conditions. p<.05 in 1 HAU vs. 100 HAU & 10 
HAU vs. 100 HAU. There is a significant difference in the amount of virus it takes to kill half 
of the cells with 1 HAU and 100 HAU and between 10 HAU and 100 HAU but not with 1 




Figure 14: TCID50 Titers in Different Glucose Concentrations. p=0.9306 There is no 
significant difference to conclude a link between the amount of virus it takes to kill half of 
the cells and the different glucose concentrations.   
DISCUSSION  
I. Concluding Remarks  
The current study contributes insights to our understanding regarding the role of 

















































60 cells, a cell-culture model for neutrophils were used to test the response to the 
PR8/H1N1 strain of the influenza virus in various glucose concentrations (16.5, 12, 7, 5.5, 
3.3 mM). The following discussion makes concluding arguments regarding the results of 
this study. 
This research was designed to study the effect of obesity-induced abnormal glucose 
metabolism on neutrophil function. Building off of the feedforward pathway theory of 
neutrophils, the original hypothesis stated that hyperglycemia would have a strong effect 
on the ability of neutrophils to function and will cause their dysregulation demonstrated by 
a lower generation of influenza virus titers and higher cell counts than areas exposed to 
normal and lower glucose concentrations. However, this research found that varying the 
glucose concentrations did not have an effect on the amount of virus needed to kill 50% of 
infected hosts (TCID50) or cell growth, but rather that the amount of virus exposure had an 
effect on cell growth and TCID50 titers.  
Virus exposure, whether 1, 10, or 100 HAU was associated with more cell death, as 
compared to the control only exposed to glucose. Influenza virus is known to induce 
apoptosis in cell cultured cells. In one study, it was found that influenza A and B viruses 
induce apoptosis in cell cultures, and apoptosis may represent a general mechanism of cell 
death is hosts infected with influenza viruses18. This could explain the lower cell counts as 
virus concentration increased. As more virus was used to infect the cells, more apoptosis 
was induced, resulting in more cell death.  
 The depletion of neutrophils (cell death) was also associated with higher TCID50 titers.  
In 100 HAU, the highest concentration of virus, all of the cells regardless of their glucose 
 30 
condition experienced a significant percent decrease in growth. Additionally, in 100 HAU, 
regardless of the glucose concentration, all of the cells generated higher TCID50’s. 
Cell clumping and change in morphological characteristics observed may correspond to 
the development of infection, however these results do not provide an explanation as to 
whether or not HL-60 cell neutrophils play a protective role during influenza infection. It 
suggests that depending on the HAU of virus (1 vs. 10 vs. 100) a different 50% infectious 
dose will be observed.   
Although this research found no significant link between hyperglycemia and 
dysregulated neutrophils (either a higher or lower cell count), it is important to note that 
this does not mean that there is no considerable link in humans or mice.  Tissue culture and 
animal models serve as important tools in research to understand the factors that 
contribute to disease and transmission outcomes. 
II. Future Applications and Implications for Further Research 
Unfortunately, the results of this experiment cannot be suggested or used as a “model” 
for human studies. A model for human research must represent humans, such as ferrets or 
guinea pigs.  
Much of this experimental design was “trial and error” designed by me, so there is a lot 
of room for improvement. In future research involving HL-60 cells as neutrophils, 100% 
neutrophil differentiation should be confirmed. In this research, neutrophil differentiation 
was confirmed if the cells expressed the morphology seen in Figure 2, however in future 
research, 100% differentiation should be confirmed either by cell surface expression of 
leukocyte antigen CD11b via flow cytometry or the capacity to generate superoxide ion via 
NBT reduction, methodologies specific to determining HL-60 cell differentiation19. 
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More research should be done, if possible, in vivo, with mice experiments where mice 
can be administered a 75 g glucose load, thus stimulating diabetes and observing naturally 
occurring neutrophils infiltrating the lungs, as did the literature referenced in this paper.  
Additionally, in this research it was observed that 100 HAU of PR8/H1N1 virus caused a 
significant amount of death in the cells. In future studies, it may be beneficial to use a lower 
concentration of virus that would perhaps not produce such a drastic harmful effect. 
Additionally, it may be beneficial to observe different virus strains, besides PR8/H1N1, as 
well. The influenza virus is an evolving/adapting virus and different viruses have varying 




I wish to thank my Principal Investigator, Melinda Beck for her support and guidance 
throughout my research. I would not have been able to complete this study without her and 
the rest of Beck Lab (office of Melinda Beck) for assistance when needed. Additionally, I 
would like to thank Jennifer Rebeles for providing me with much assistance, William Green, 










1. Mancuso P, O′Brien E, Prano J, Goel D, Aronoff DM (2014) No Impairment in Host 
Defense against Streptococcus pneumoniae in Obese CPEfat/fat Mice. [Abstract]. PLoS 
ONE 9(9): e106420. doi:10.1371/journal.pone.0106420 
2. J A. Jeevendra Martyn, M.D., F.R.C.A., F.C.C.M., Masao Kaneki, M.D., Ph.D., Shingo 
Yasuhara, M.D., Ph.D.; Obesity-induced Insulin Resistance and Hyperglycemia: 
Etiologic Factors and Molecular Mechanisms. Anesthesiology 2008;109(1):137-148. 
doi: 10.1097/ALN.0b013e3181799d45.  
3. Hill, N. R., Oliver, N. S., Choudhary, P., Levy, J. C., Hindmarsh, P., & Matthews, D. R. 
(2011). Normal Reference Range for Mean Tissue Glucose and Glycemic Variability 
Derived from Continuous Glucose Monitoring for Subjects Without Diabetes in 
Different Ethnic Groups. Diabetes Technology & Therapeutics, 13(9), 921–928. 
http://doi.org/10.1089/dia.2010.0247 
4. Florkowski, C. (2013). HbA1c as a Diagnostic Test for Diabetes Mellitus – Reviewing 
the Evidence. The Clinical Biochemist Reviews, 34(2), 75–83. 
5. World Health Organization . Second Report WHO Technical Report Series 646. 
Geneva: WHO; 1980. WHO Expert Committee on Diabetes Mellitus. Retrieved from 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3799221/.  
6. Paich, H. A., Sheridan, P. A., Handy, J., Karlsson, E. A., Schultz-Cherry, S., Hudgens, M. 
G., … Beck, M. A. (2013). Overweight and obese adult humans have a defective 
cellular immune response to pandemic H1N1 influenza A virus. Obesity (Silver 
Spring, Md.), 21(11), 2377–2386. http://doi.org/10.1002/oby.20383 
7. Centers for Disease Control and Prevention. (2014). Key facts about influenza (flu) 
 33 
& flu vaccine. Atlanta, GA: Centers for Disease Control and Prevention. 
8. Iwasaki, A., & Pillai, P. S. (2014). Innate immunity to influenza virus infection. 
Nature Reviews. Immunology, 14(5), 315–328. http://doi.org/10.1038/nri3665 
9. Tate, M. D., Ioannidis, L. J., Croker, B., Brown, L. E., Brooks, A. G., & Reading, P. C. 
(2011). The role of neutrophils during mild and severe influenza virus infections of 
mice. PloS one, 6(3), e17618. 
10. Brandes M, Klauschen F, Kuchen S, Germain RN. A systems analysis identifies a 
feed-forward inflammatory circuit leading to lethal influenza infection . Cell 
(2013).  
11. Mócsai, A. (2013). Diverse novel functions of neutrophils in immunity, 
inflammation, and beyond. The Journal of Experimental Medicine, 210(7), 1283–
1299. http://doi.org/10.1084/jem.20122220  
12. M., Luo, P., Tang, R., Peng, Y., Yu, S., Huang, W., & He, L. (2015). Relationship 
between neutrophil-lymphocyte ratio and insulin resistance in newly diagnosed 
type 2 diabetes mellitus patients. BMC endocrine disorders, 15(1),  
13. Drescher, B., & Bai, F. (2013). Neutrophil in Viral Infections, Friend or Foe? Virus 
Research, 171(1), 1–7. http://doi.org/10.1016/j.virusres.2012.11.002 
14. (Nature (Lond.) 270:347-349,1977). Tissue Culture Facility. University of North 
Caroina at Chapel Hill.  
15. Olins, A. L., & Olins, D. E. (2004). Cytoskeletal influences on nuclear shape in 
granulocytic HL-60 cells. BMC Cell Biology, 5, 30. http://doi.org/10.1186/1471-
2121-5-30.  
16. Corning Incorporated 
 34 
17. Millius, A., & Weiner, O. D. (2010). Manipulation of Neutrophil-Like HL-60 Cells for 
the Study of Directed Cell Migration. Methods in Molecular Biology (Clifton, N.J.), 
591, 147–158. http://doi.org/10.1007/978-1-60761-404-3_9 
18.  Hinshaw V S, Olsen C W, Dybdahl-Sissoko N, Evans D. Apoptosis: a mechanism of 
cell killing by influenza A and B viruses. J Virol. 1994;68:3667–3673. 
19. Clynes, M. (Ed.). (2012). Animal cell culture techniques, pp 269-271. Springer 
Science & Business Media. 
 
